PLEASANTON, Calif.--(BUSINESS WIRE)--Diagnostic Biosystems (DBS), a specialty immunohistochemistry (IHC) reagent company, announces the availability of products for clinical use in the US.
Founded in 1994 as a life science supplier of novel, high quality IHC products in over 45 countries, DBS introduces a complete selection of IVD labeled staining reagents suitable for manual and automated staining platforms. DBS offers IVD labeled concentrated and pre-diluted ready-to-use primary antibodies and immunostaining detection systems for rabbit and mouse antibodies: advanced biotin-free polymer systems as well as traditional streptavidin-biotin systems labeled with horseradish peroxidase or alkaline phosphatase.
Unique to the Diagnostic Biosystems offering are antibody cocktails and proprietary chromogens for multicolor staining, focused on improving sensitivity and defining morphology on one tissue section for potentially cancerous cells. Novel antibodies and multi-stain products include:
* PIN4
* DOG-1
* Napsin A
* OCT4
* PermaRed/AP-Auto
* PermaBlue/AP
* PermaGreen/AP
* Stable DAB/Plus
“Diagnostic Biosystems is focused on developing clinically relevant, IVD labeled products for pathologists in the US. We are dedicated to providing the highest quality reagents for clinical labs. We understand high quality staining is the key to better diagnosis by Pathologists. We are committed to improving immunostaining one slide at a time," said Dr. Bipin Gupta, PhD, President & CEO.
For additional information on the product availability, contact customer care at 888-896-3350 or visit www.dbiosys.com. IVD products are available immediately.
About Diagnostic Biosystems Company:
Diagnostic Biosystems is a leading developer of high quality Immunohistochemistry reagents. Founded in 1994, the company is dedicated to high quality antibody production and development of novel multiplex staining reagents. Building on its strong global presence, Diagnostic Biosystems produces novel, clinically relevant tools for pathology market including: monoclonal and polyclonal antibodies, a wide range of detection systems and ancillary reagents for high quality immunostaining. Custom Monoclonal and Polyclonal Antibody Production Services include peptide synthesis, in vitro and in vivo antibody production, purification and conjugation.
Diagnostic BioSystems is an FDA registered medical device manufacturer, operating under FDA 21CFR Part 820 Quality System Regulations and certified under ISO 9001:2000 Quality Management System International standards, manufacturing CE marked medical devices, for use in the European market.
Contact:
Diagnostic BioSystems Martha Townsend, 888-896-3350 martha.townsend@dbiosys.com
